nine children with acute non-lymphocytic leukemia ( anll ) , ages 16 months to 16 years ( median 7 years ) , and 15 children with acute lymphocytic leukemia ( all ) , ages 10 months to 18 years ( median 5 years ) , were treated with 5-day courses of mitoxantrone ( novantrone ; dihydroxyanthracenedione ) as induction therapy .
C0023467
acute non-lymphocytic leukemia
C0026259
dihydroxyanthracenedione